Covid: Paxlovid receives definitive registration from Anvisa – 01/06/2024 – Health
Pfizer's Covid drug, Paxlovid, received definitive registration from Anvisa (National Health Surveillance Agency) on December 29th. Previously, its use had...
Pfizer's Covid drug, Paxlovid, received definitive registration from Anvisa (National Health Surveillance Agency) on December 29th. Previously, its use had...
Brazilian researchers are waiting for an opinion from Anvisa (National Health Surveillance Agency) to start clinical trials of a new...